| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | XOMA CORP DEL | 70,000 | 272,000 | 0.29% | Call | |
| 2 | STEMLINE THERAPEUTICS INC | 25,000 | 294,000 | 0.31% | ||
| 3 | ZOGENIX INC | 250,000 | 420,000 | 0.44% | ||
| 4 | ALIMERA SCIENCES INC | 100,000 | 461,000 | 0.48% | ||
| 5 | Sunesis Pharmaceuticals I | 200,000 | 602,000 | 0.63% | ||
| 6 | CYTOKINETICS INC | 100,000 | 672,000 | 0.71% | ||
| 7 | ARIAD PHARMACEUTICALS ORD (NMS) | 100,000 | 827,000 | 0.87% | ||
| 8 | FIBROCELL SCIENCE INC | 157,769 | 831,000 | 0.87% | ||
| 9 | SUPERNUS PHARMACEUTICALS INC | 50,000 | 849,000 | 0.89% | Call | |
| 10 | SORRENTO THERAPEUTICS INC COM NEW | 50,000 | 881,000 | 0.93% | ||
| 11 | AMARIN CORP PLC | 400,000 | 984,000 | 1.03% | Call | |
| 12 | Apricus Biosciences, Inc. | 650,000 | 1,112,000 | 1.17% | ||
| 13 | ProShares VIX Short-Term Futures | 100,000 | 1,342,000 | 1.41% | Call | |
| 14 | AEGERION PHARMACEUTICALS INC | 80,000 | 1,518,000 | 1.59% | ||
| 15 | ABBVIE INC | 25,000 | 1,680,000 | 1.76% | ||
| 16 | Sunesis Pharmaceuticals I | 700,000 | 2,107,000 | 2.21% | Call | |
| 17 | ALLIQUA BIOMEDICAL INC | 421,000 | 2,219,000 | 2.33% | ||
| 18 | PROSHARES TR | 100,000 | 2,872,000 | 3.02% | ||
| 19 | ALLERGAN PLC | 10,000 | 3,035,000 | 3.19% | ||
| 20 | PROSHARES ULTRASHORT RUSSELL2000 | 100,000 | 3,476,000 | 3.65% | Call | |
| 21 | PROSHARES ULTRASHORT RUSSELL2000 | 100,000 | 3,476,000 | 3.65% | ||
| 22 | CRYOLIFE INC | 370,000 | 4,174,000 | 4.38% | ||
| 23 | QUEST DIAGNOSTICS INC | 66,208 | 4,801,000 | 5.04% | ||
| 24 | PFIZER INC | 150,000 | 5,030,000 | 5.28% | ||
| 25 | ASTRAZENECA PLC | 100,000 | 6,371,000 | 6.69% | ||
| 26 | ANI PHARMACEUTICALS INC | 125,000 | 7,756,000 | 8.15% | ||
| 27 | MANNKIND CORP. | 1,470,000 | 8,364,000 | 8.78% | Put | |
| 28 | PROSHARES TR | 300,000 | 8,616,000 | 9.05% | Call | |
| 29 | QLT INC | 2,107,200 | 8,703,000 | 9.14% | ||
| 30 | Albany Molecular | 567,400 | 11,473,000 | 12.05% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-15-006071, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
